These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1314018)

  • 41. MCMI-III-derived typological analysis of cocaine and heroin addicts.
    Craig RJ; Bivens A; Olson R
    J Pers Assess; 1997 Dec; 69(3):583-95. PubMed ID: 9501486
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation of the antibody titers with serum prolactin levels and their clinical course in patients with anti-prolactin autoantibody.
    Hattori N; Ikekubo K; Ishihara T; Moridera K; Hino M; Kurahachi H
    Eur J Endocrinol; 1994 May; 130(5):438-45. PubMed ID: 8180669
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DHEAS and POMS measures identify cocaine dependence treatment outcome.
    Wilkins JN; Majewska MD; Van Gorp W; Li SH; Hinken C; Plotkin D; Setoda D
    Psychoneuroendocrinology; 2005 Jan; 30(1):18-28. PubMed ID: 15358439
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The diagnosis of hyperprolactinemia in clinical practice].
    Lech MM
    Ginekol Pol; 2005 Dec; 76(12):1008-13. PubMed ID: 16566383
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Personality disorders and associated features in cocaine-dependent inpatients.
    Kranzler HR; Satel S; Apter A
    Compr Psychiatry; 1994; 35(5):335-40. PubMed ID: 7995024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Issues in the assessment of personality disorder and substance abuse using the Millon Clinical Multiaxial Inventory (MCMI-II).
    Flynn PM; McCann JT; Fairbank JA
    J Clin Psychol; 1995 May; 51(3):415-21. PubMed ID: 7560145
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cocaine use and dependence in young adults: associated psychiatric disorders and personality traits.
    Kilbey MM; Breslau N; Andreski P
    Drug Alcohol Depend; 1992 Feb; 29(3):283-90. PubMed ID: 1559435
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Independent versus substance-induced major depressive disorder in substance-dependent patients: observational study of course during follow-up.
    Nunes EV; Liu X; Samet S; Matseoane K; Hasin D
    J Clin Psychiatry; 2006 Oct; 67(10):1561-7. PubMed ID: 17107247
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Misleading diagnosis of hyperprolactinemia in women].
    Paepegaey AC; Veron L; Wimmer MC; Christin-Maitre S
    Gynecol Obstet Fertil; 2016 Mar; 44(3):181-6. PubMed ID: 26966035
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Empirical assessment of the self-medication hypothesis among dually diagnosed inpatients.
    Castaneda R; Lifshutz H; Galanter M; Franco H
    Compr Psychiatry; 1994; 35(3):180-4. PubMed ID: 8045107
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Levels of dissociation in detoxified substance abusers and their relationship to chronicity of alcohol and drug use.
    Wenzel K; Bernstein DP; Handelsman L; Rinaldi P; Ruggiero J; Higgins B
    J Nerv Ment Dis; 1996 Apr; 184(4):220-7. PubMed ID: 8604031
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bromocriptine in cocaine withdrawal--does it work?
    Teller DW; Devenyi P
    Int J Addict; 1988 Nov; 23(11):1197-205. PubMed ID: 3069753
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Prolactin and the laboratory].
    Veloza A; Prazeres S
    Acta Med Port; 2011 Dec; 24 Suppl 4():1029-34. PubMed ID: 22863514
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An examination of the stability of the MMPI Personality Disorder Scales.
    Hurt SW; Clarkin JF; Morey LC
    J Pers Assess; 1990; 54(1-2):16-23. PubMed ID: 2313537
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hyperprolactinemia: etiology, diagnosis, and management.
    Mah PM; Webster J
    Semin Reprod Med; 2002 Nov; 20(4):365-74. PubMed ID: 12536359
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of hyperprolactinemia in schizophrenia: association with typical and atypical antipsychotic treatment.
    Montgomery J; Winterbottom E; Jessani M; Kohegyi E; Fulmer J; Seamonds B; Josiassen RC
    J Clin Psychiatry; 2004 Nov; 65(11):1491-8. PubMed ID: 15554761
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comorbid substance abuse and recovery from acute psychiatric relapse.
    Sanguineti VR; Samuel SE
    Hosp Community Psychiatry; 1993 Nov; 44(11):1073-6. PubMed ID: 8288176
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Substance abuse in an inpatient psychiatric sample.
    Brady K; Casto S; Lydiard RB; Malcolm R; Arana G
    Am J Drug Alcohol Abuse; 1991; 17(4):389-97. PubMed ID: 1746501
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Axis II comorbidity of substance use disorders among patients referred for treatment of personality disorders.
    Skodol AE; Oldham JM; Gallaher PE
    Am J Psychiatry; 1999 May; 156(5):733-8. PubMed ID: 10327906
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Is the assessment of biological activity of prolactin essential in the diagnosis of hyperprolactinemia?].
    Kostrzak A; Warenik-Szymankiewicz A; Meczekalski B
    Pol Merkur Lekarski; 2010 May; 28(167):359-61. PubMed ID: 20568397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.